Together we can accelerate towards a climate neutral society
Watch the film

Time to rethink the big picture

A climate-neutral society is achievable if we accelerate vital changes in how we all produce and consume. One process and one product at a time, we must reduce our emissions across the board. Biotechnology holds one of the keys: it’s already changing the proteins we eat, the detergents we use, the transportation fuels we rely on and the way we capture carbon – it goes on. And with our industry partners, we’re accelerating these changes every day.

And there’s more good news. Biotechnology doesn’t just address climate change; it also helps us solve some of the other major challenges of our time, such as transforming our food systems and enabling better health.

With biotechnology, we can rethink the big picture, so that we can move forward in all directions together.

With biotechnology, we can improve something very fundamental: how we produce and how we consume.

Ester Baiget

CEO of Novozymes

With biotechnology, we can improve something very fundamental: how we produce and how we consume.

Ester Baiget

CEO of Novozymes

Watch Ester explain more

Every tonne counts

55 billion tonnes of CO2 equivalents - that was the amount of greenhouse gasses we emitted into our atmosphere in 2021. That’s the same weight as 10,000 Giza pyramids. If we focus only on the big number, reducing these emissions can seem an overwhelming task.

But if we break it down, and use available technology – such as biotechnology - we can accelerate towards a climate-neutral society.

We need collaboration for the Paris agreement to succeed

Half of the total reductions we need have
to be made by 2030
Measured in million tonnes of CO2

View source

We emit billions of tonnes of CO2 into our atmosphere every year - last year it was 55 billion tonnes. To reach the Paris Climate Agreement’s target of a maximum increase of 1.5°C, we need to act fast and we need to act together. Our emissions must be reduced to 8.5 billion tonnes of CO2 by 2050. And we need to achieve half of this amount by 2030 - that’s just eight years away.

We need governments, businesses and investors to step up and work together to take the action climate science demands. Knowledge is key.

That’s why we’re constantly working to learn more from our partner organizations and our customers.

Together we’re finding new and better ways to use biotechnology solutions to accelerate towards a climate-neutral society.

Examples include:
Helping companies reach their own climate and net-zero targets
We help our customers and partners to use biotech to reach their net-zero targets. We also provide insights to help shape industry standards.
Advocating for clear emissions reduction markets and frameworks
“Carbon pricing” and “carbon taxation” cuts across many industries. They’re essential to ensure the economic and financial foundations needed for a rapid transition to climate neutrality. We advocate for clear and ambitious frameworks to guide business and support investments.
Helping countries see the potential of biotech
Each country has its own climate target and action plan. These Nationally Determined Contributions (NDCs) are investment, industry and policy plans updated every five years. We work with countries to show how NDCs can fulfill their potential and how biotechnology can help.

Our global partnerships for climate action

Mouse over to see more information

International Chamber of Commerce

UN Global Compact

Science Based Targets Initiative

The B Team

The World Economic Forum

The United States Council for International Business

Danish Government Climate Partnerships

The Brazilian Bio Innovation Association

Scoping the future

When talking about greenhouse gases (GHG) emissions, scope is the buzz word on everyone’s lips.

Here is a breakdown of scopes 1, 2 and, 3 and how they look for Novozymes.

Hover over the three Scope areas to see the categories.

Scope 1
Direct GHG emissions that occur from sources controlled or owned by an organization
At Novozymes, our Scope 1 is a small percentage of total emissions, and our largest emission source is via the use of natural gas in our production facilities.
Scope 2
Indirect GHG emissions associated with purchased energy
This includes gases associated with the generation of purchased electricity, steam, heating and cooling. At Novozymes, the largest contributor to our Scope 2 is our electricity consumption, and we have committed to source 100% Renewable Electricity by 2030.
Scope 3
All other GHG emissions resulting from activities not owned or controlled by Novozymes, but which we impact in our value chain
Scope 3 is also referred to as value chain emissions. These can look very differently depending on the nature and location of a business. At Novozymes, it represents the majority of our total GHG emissions.

The following emission sources are the ones most material to Novozymes:

• Purchased goods and services

• Other energy-related activities not included in Scope 1 or Scope 2

• Transportation paid by Novozymes

• Business travel

Leading the way
with Science-Based Targets

The Science-Based Targets initiative provides a clearly-defined pathway for companies to reduce greenhouse gas (GHG) emissions and reach net zero by 2050.
Climate action is an integral part of Novozymes’ business strategy. We have been leading the way for many years. We were among the first few companies to set a validated Science-Based Target in line with the 1.5°C pathway.

As a manufacturing company, we have significant climate impact in our value chain. That’s why our science-based targets cover scopes 1, 2 and 3. We’re fully committed to a net-zero future across all three scopes. As part of our latest business strategy, we’ve raised our ambitions to a 50% reduction in absolute emissions across all three scopes by 2030. There’s no time to waste.

Want to learn more?

Connect with us to see how we can rethink tomorrow, together.